Part 1/11:
The US-China Pharmaceutical Clash: A Deep Dive into the Shifting Landscape
The geopolitical tension between the United States and China has taken a new turn in the pharmaceutical arena. Recently, US President Donald Trump announced plans to impose tariffs on pharmaceutical imports, specifically targeting China—one of the world’s largest exporters of pharmaceutical products. This move signals a broader strategic effort by Washington to diminish China’s dominance in the biotech sector, which has seen unprecedented growth and innovation over the past decade.